Lessee, Operating Lease, Liability, to be Paid in USD of Chemomab Therapeutics Ltd. from Q4 2019 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payment for operating lease.
Summary
Chemomab Therapeutics Ltd. quarterly Lessee, Operating Lease, Liability, to be Paid history and change rate from Q4 2019 to Q4 2024.
  • Chemomab Therapeutics Ltd. Lessee, Operating Lease, Liability, to be Paid for the quarter ending 31 Dec 2024 was $346K, a 25.4% decline year-over-year.
Lessee, Operating Lease, Liability, to be Paid, Quarterly (USD)
Lessee, Operating Lease, Liability, to be Paid, YoY Quarterly Change (%)

Chemomab Therapeutics Ltd. Quarterly Lessee, Operating Lease, Liability, to be Paid (USD)

Period Value YoY Chg Change % Date Report Filed
Q4 2024 $346K -$118K -25.4% 31 Dec 2024 20-F 04 Apr 2025
Q4 2023 $464K +$245K +112% 31 Dec 2023 20-F 28 Mar 2024
Q4 2022 $219K -$152K -41% 31 Dec 2022 10-K 20 Mar 2023
Q4 2021 $371K +$166K +81% 31 Dec 2021 10-K 30 Mar 2022
Q4 2020 $205K -$995K -82.9% 31 Dec 2020 10-K 09 Mar 2021
Q4 2019 $1.2M 31 Dec 2019 10-K 17 Mar 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.